These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15272539)

  • 41. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
    Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F
    J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization.
    Rossi E; Villanacci V; Bassotti G; Casa DD; Missale G; Minelli L; Cestari R
    Diagn Mol Pathol; 2006 Sep; 15(3):125-30. PubMed ID: 16932066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
    Giltnane JM; Murren JR; Rimm DL; King BL
    Histopathology; 2006 Aug; 49(2):161-9. PubMed ID: 16879393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.
    Sartelet H; Lagonotte E; Lorenzato M; Duval I; Lechki C; Rigaud C; Cucherousset J; Durlach A; Graesslin O; Abboud P; Doco-Fenzy M; Quereux C; Costa B; Polette M; Munck JN; Birembaut P
    J Clin Pathol; 2005 Aug; 58(8):864-71. PubMed ID: 16049291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Determination of HER2 by fluorescence in situ hybridization (FISH) in breast cancer. Experience of the Reference Laboratory of Lisbon].
    André S; Tomás AR; Fonseca R
    Acta Med Port; 2005; 18(6):417-22. PubMed ID: 16684481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HER2 status in breast cancer determined by IHC and FISH: comparison of the results.
    Mrozkowiak A; Olszewski WP; Piaścik A; Olszewski WT
    Pol J Pathol; 2004; 55(4):165-71. PubMed ID: 15757204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative PCR and HER2 testing in breast cancer: a technical and cost-effectiveness analysis.
    Barberis M; Pellegrini C; Cannone M; Arizzi C; Coggi G; Bosari S
    Am J Clin Pathol; 2008 Apr; 129(4):563-70. PubMed ID: 18343783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of two HER-2 FISH kits on formalin-fixed paraffin-embedded tissues: signal detection and simple procedure].
    Uhara M; Matsuda K; Shimojyo Y; Hidaka E; Kumagai T; Uehara T; Sano K; Honda T
    Rinsho Byori; 2010 Jan; 58(1):25-9. PubMed ID: 20169940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between aneuploidy of chromosome 17 and amplification of HER-2/neu gene in the different histological type of breast cancer].
    Kuroso K; Ueda Y; Mori Y
    Rinsho Byori; 2004 Nov; 52(11):897-9. PubMed ID: 15658468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy.
    Bloom K; Harrington D
    Am J Clin Pathol; 2004 May; 121(5):620-30. PubMed ID: 15151201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of archival frozen tumor tissue imprint specimens for fluorescence in situ hybridization.
    Demetrick DJ
    Mod Pathol; 1996 Feb; 9(2):133-6. PubMed ID: 8657719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amplification and over-expression of the neu oncogene in human breast carcinomas.
    van de Vijver MJ; Mooi WJ; Peterse JL; Nusse R
    Eur J Surg Oncol; 1988 Apr; 14(2):111-4. PubMed ID: 3360152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.
    Suo Z; Daehli KU; Lindboe CF; Borgen E; Bassarova A; Nesland JM
    Int J Surg Pathol; 2004 Oct; 12(4):311-8. PubMed ID: 15494857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples.
    Klijanienko J; Couturier J; Galut M; El-Naggar AK; Maciorowski Z; Padoy E; Mosseri V; Vielh P
    Cancer; 1999 Oct; 87(5):312-8. PubMed ID: 10536358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies.
    Sauter G; Feichter G; Torhorst J; Moch H; Novotna H; Wagner U; Dürmüller U; Waldman FM
    Acta Cytol; 1996; 40(2):164-73. PubMed ID: 8629392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.